schizandrol b has been researched along with Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, K; Hung, TM; Kang, SS; Kim, SH; Kim, YS; Lee, SM | 1 |
| Cyong, JC; Furuya, M; Iijima, K; Ki, SM; Kobayashi, T | 1 |
2 other study(ies) available for schizandrol b and Hepatic Failure
| Article | Year |
|---|---|
Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Caspase 3; Cyclooctanes; Dioxoles; DNA Fragmentation; Galactosamine; Glutathione; Lignans; Lipid Peroxidation; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred ICR; Mitochondria, Liver; Mitochondrial Swelling; Oxidative Stress; Protective Agents; Tumor Necrosis Factor-alpha | 2008 |
Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cell Line; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Hepatitis C, Chronic; Humans; Lignans; Liver Diseases; Liver Failure; Medicine, Kampo; Mice; Middle Aged; Plant Extracts; RNA, Viral; Time Factors | 2000 |